[{"address1": "Fitzwilliam Court", "address2": "1st Floor Leeson Close", "city": "Dublin", "zip": "D02 YW24", "country": "Ireland", "phone": "353 1 669 4820", "website": "https://www.iterumtx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Mr. Corey N. Fishman", "age": 58, "title": "President, CEO & Director", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 1298811, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Judith M. Matthews", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 747774, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael W. Dunne M.D.", "age": 63, "title": "Strategic Advisor & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 115000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tom  Loughman Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Louise  Barrett", "title": "Senior Vice President of Legal Affairs & Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven I. Aronin M.D.", "title": "Senior VP & Head of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.06, "open": 1.09, "dayLow": 1.03, "dayHigh": 1.09, "regularMarketPreviousClose": 1.06, "regularMarketOpen": 1.09, "regularMarketDayLow": 1.03, "regularMarketDayHigh": 1.09, "beta": 2.256, "forwardPE": -1.9090908, "volume": 69223, "regularMarketVolume": 69223, "averageVolume": 316330, "averageVolume10days": 174960, "averageDailyVolume10Day": 174960, "bid": 1.01, "ask": 1.06, "bidSize": 300, "askSize": 400, "marketCap": 23841298, "fiftyTwoWeekLow": 0.622, "fiftyTwoWeekHigh": 2.5, "fiftyDayAverage": 1.1408, "twoHundredDayAverage": 1.429825, "currency": "USD", "enterpriseValue": 33744292, "floatShares": 21960102, "sharesOutstanding": 22706000, "sharesShort": 341652, "sharesShortPriorMonth": 443601, "sharesShortPreviousMonthDate": 1723680000, "dateShortInterest": 1726185600, "sharesPercentSharesOut": 0.015, "heldPercentInsiders": 0.01811, "heldPercentInstitutions": 0.030469999, "shortRatio": 0.92, "shortPercentOfFloat": 0.0156, "impliedSharesOutstanding": 22706000, "bookValue": -0.658, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -28337000, "trailingEps": -1.83, "forwardEps": -0.55, "lastSplitFactor": "1:15", "lastSplitDate": 1660780800, "enterpriseToEbitda": -0.903, "52WeekChange": 0.45833337, "SandP52WeekChange": 0.34083736, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ITRM", "underlyingSymbol": "ITRM", "shortName": "Iterum Therapeutics plc", "longName": "Iterum Therapeutics plc", "firstTradeDateEpochUtc": 1527255000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "2a47ad90-f2ae-3045-b6c4-2f53ded8d73b", "messageBoardId": "finmb_318354064", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.05, "targetHighPrice": 7.0, "targetLowPrice": 5.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 11717000, "totalCashPerShare": 0.516, "ebitda": -37364000, "totalDebt": 21620000, "quickRatio": 0.71, "currentRatio": 0.816, "returnOnAssets": -0.73347, "freeCashflow": -28464500, "operatingCashflow": -41950000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-03"}]